Machine learning from the CARDAMON trial identifies a carfilzomib-specific mutational response signature https://www.medrxiv.org/content/10.1101/2023.04.08.23288287
Machine learning from the CARDAMON trial identifies a carfilzomib-specific mutational response signature https://www.medrxiv.org/content/10.1101/2023.04.08.23288287